Information provided by Healthline.com

erlotinib Health Article

Licensed from Print
Table of Contents
Doctor-reviewed Information, Multum Drug Directory, 2006
Page: 1 2 Next >
Generic name(s):

erlotinib

Brand name(s):

Tarceva

What is the most important information I should know about erlotinib?

If you experience any of the following serious side effects from erlotinib, contact your doctor immediately:

  • an allergic reaction (including difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives);

  • lung problems (especially new or worsening difficulty breathing, shortness of breath, increased coughing, fever, or chest pain);

  • severe or persistent nausea, vomiting, loss of appetite, or diarrhea; or

  • eye pain or irritation.

What is erlotinib?

Erlotinib is a cancer chemotherapy medication. Erlotinib interferes with the growth of cancer cells and slows their growth and spread in the body.

Erlotinib is used in the treatment of non-small cell lung cancer.

Erlotinib may also be used for purposes other than those listed in this medication guide.

What should I discuss with my healthcare provider before taking erlotinib?

Do not use erlotinib without first talking to your doctor if you have
  • liver disease; or
  • lung or breathing problems (other than lung cancer).

You may not be able to take erlotinib, or you may require a dosage adjustment or special monitoring if you have any of the conditions listed above.

Erlotinib is in the FDA pregnancy category D. This means that it is known to be harmful to an unborn baby. Do not use erlotinib without first talking to your doctor if you are pregnant or could become pregnant during treatment. Birth control should be used during treatment with erlotinib and for at least 2 weeks after treatment completion. It is not known whether erlotinib passes into breast milk. Do not take erlotinib without first talking to your doctor if you are breast-feeding a baby.

How should I use erlotinib?

Take erlotinib at least one hour before or two hours after eating.

Take each dose of erlotinib with a full glass of water.

It is important to take erlotinib regularly to get the most benefit.

Your doctor may want you to have blood tests and other medical evaluations during treatment with erlotinib to monitor progress and side effects.

Your doctor will determine the correct amount, frequency and duration of treatment with erlotinib depending upon the type of cancer being treated and other factors. Talk to your doctor if you have any questions or concerns regarding the treatment schedule.

Store this medication at room temperature away from moisture and heat.

What happens if I miss a dose?

Contact your doctor if you miss a dose of erlotinib.

What happens if I overdose?

If an overdose of erlotinib is suspected, seek emergency medical attention or contact your healthcare provider immediately.

Symptoms of a erlotinib overdose tend to be similar to side effects caused by the medication, although often more severe.

What should I avoid while using erlotinib?

There are no restrictions on food, beverages, or activity during treatment with erlotinib unless otherwise directed by your doctor.

What are the possible side effects of erlotinib?

If you experience any of the following serious side effects from erlotinib, contact your doctor immediately:

  • an allergic reaction (including difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; or hives);

  • lung problems (difficulty breathing, shortness of breath, increased coughing, fever, or chest pain);

  • severe or persistent nausea, vomiting, loss of appetite, or diarrhea; or

  • eye pain or irritation.

Other, less serious side effects may be more likely to occur. Continue taking erlotinib and talk to your doctor if you experience:

  • mild to moderate nausea, vomiting, loss of appetite, or diarrhea;

  • skin rash, dryness, itching, or acne; or

  • weakness.

Other side effects have also been reported. Discuss with your doctor any side effect that occurs during treatment with erlotinib.

Page: 1 2 Next >

advertisement

Back to Top Print

Use of this Web site constitutes acceptance of our Terms and Conditions of Use and Privacy Policy.